News

Current Therapies for AK and Precancerous Lesions Subpar

Publish date: July 31, 2011

 

EXPERT ANALYSIS FROM THE SDEF SUMMIT IN AESTHETIC MEDICINE

Dr. Rubin disclosed that he has received research support and consulting fees from Medicis. SDEF and this news organization are owned by Elsevier.

Pages

Recommended Reading

Point/Counterpoint: Is Mohs Surgery Being Overutilized?
MDedge Dermatology
Steaming Veins: The Skinny Podcast
MDedge Dermatology
Spitz Nevi Do Not Predict Pediatric Melanoma
MDedge Dermatology
Risk for Melanoma in Kids Not Clear Cut
MDedge Dermatology
Giant Congenital Melanocytic Nevi May Signal Melanoma in Kids
MDedge Dermatology
Melanoma Treatment Ipilimumab Approved Europe-Wide
MDedge Dermatology
Real-Time Monitoring of Melanoma Markers Predicts Relapse
MDedge Dermatology
Blog: Hats Off to Tanzania Albinism Project
MDedge Dermatology
Video of the Week: More Melanoma Treatments on the Way?
MDedge Dermatology
Real-Time Monitoring of Melanoma Markers Predicts Relapse
MDedge Dermatology